Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Ethnopharmacology

This article is part of the Research TopicComputational Approaches in Pharmacological Research and Drug Development: How to Overcome the Challenges of Complex Matrices in Ethnopharmacology, Therapeutics, and Formulation DesignView all articles

Molecular Docking and Pharmacological Investigations of Folenolide for Its Analgesic, Anti-Inflammatory and Antipyretic Applications

Provisionally accepted
Faryal  Liaqat AliFaryal Liaqat Ali1Fazli  KhudaFazli Khuda1Atif  Ali Khan KhalilAtif Ali Khan Khalil2Asif  JanAsif Jan1Abdur  RasheedAbdur Rasheed1Muhammad  Asif KhanMuhammad Asif Khan3Syed  Shaukat AliSyed Shaukat Ali1Asmat  UllahAsmat Ullah4*
  • 1University of Peshawar, Peshawar, Pakistan
  • 2Yeungnam University, Gyeongsan-si, Republic of Korea
  • 3Sarhad University of Science & Information Technology, Peshawar, Pakistan
  • 4Spinghar University Faculty of Medicine, Jalalabad, Afghanistan

The final, formatted version of the article will be published soon.

Background: Folenolide, a novel compound, was investigated for its pharmacological potential, focusing on its analgesic, anti-inflammatory, and antipyretic effects, along with its safety profile and potential molecular targets, using in-vivo models and molecular docking studies. Methods: In-vivo models mouse models were used to assess acute toxicity and analgesic, anti-inflammatory, and antipyretic activity. Molecular docking simulations were conducted against key targets, including COX-2, lipoxygenase, opioid, histamine, and tankyrase receptors, to explore their potential mechanisms of action. Results: Folenolide showed no signs of acute toxicity. The analgesic model exhibited significant peripheral analgesia in the acetic acid-induced writhing test (31.07% and 50.13% inhibition at 3 and 6 mg/kg, respectively; p< 0.01) and potent central analgesia in the hot plate test (maximum effect at 6 mg/kg; p< 0.0001). Formalin test results confirmed both neurogenic and inflammatory phase inhibition (69.17–78.26%). Anti-inflammatory efficacy was marked in carrageenan-induced paw edema (84.3–94.98% reduction), histamine-induced edema (87.29–88.6%), and xylene-induced ear edema (6.19–8.19% weight gain suppression) (p< 0.05). Folenolide also displayed antipyretic effects, significantly reducing the rectal temperature in yeast-induced fever models. Molecular docking revealed favorable binding affinities (ΔG ranging from -4.4 to -5.9 kJ/mol) with key targets. Conclusions: Folenolide exhibits strong analgesic, anti-inflammatory, and antipyretic activities with a favorable safety profile. Its pharmacodynamic effects are supported by its molecular interactions with cyclooxygenase (COX), opioids, and histamine receptor targets. These findings highlight its potential as a promising therapeutic agent for pain, inflammation, and fever management.

Keywords: folenolide, acute toxicity, Inflammation, analgesic, Antipyretic, molecular docking

Received: 02 Jul 2025; Accepted: 24 Oct 2025.

Copyright: © 2025 Ali, Khuda, Khalil, Jan, Rasheed, Khan, Ali and Ullah. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Asmat Ullah, drasmatullah08@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.